¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fat cells"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
  • fat-soluble
    Áö¿ë¼º-
  • fat-storing cell
    Áö¹æÀúÀå¼¼Æ÷
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • infrapatellar fat pad
    ¹«¸­¾Æ·¡Áö¹æÃ¼
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • molecular fat
    ºÐÀÚÁö¹æ
  • mutton-fat keratic precipitate
    ±»±â¸§°¢¸·Ä§Âø¹°
  • masked fat
    ¼ûÀºÁö¹æ
  • neutral fat
    Áß¼ºÁö¹æ
  • nodular fat necrosis
    °áÀýÁö¹æ±«»ç
  • orbital fat
    ´«È®Áö¹æ, ¾È¿ÍÁö¹æ
  • pararenal fat
    ÄáÆÏÁÖÀ§Áö¹æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ°íÁö¹æÇ÷Áõ
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • masked fat
    °áÇÕÁö¹æ
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • molecular fat
    ºÐÀÚÁö¹æ
  • neutral fat
    Áß¼ºÁö¹æ
  • pararenal fat
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
  • perirenal fat
    ÄáÆÏÁö¹æÇǸ·
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • infrapatellar fat pad
    ¹«¸­¹ØÁö¹æÃ¼
  • mutton-fat keratic precipitate
    ±»±â¸§°¢¸·Ä§Âø¹°
  • nodular fat necrosis
    °áÀýÁö¹æ±«»ç
  • subcutaneous fat necrosis
    ÇǺιØÁö¹æ±«»ç, ÇÇÇÏÁö¹æ±«»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Ganglion cells
    ½Å°æÀý¼¼Æ÷(ãêÌèï½á¬øà)
  • Gastrin cells
    °¡½ºÆ®¸°¼¼Æ÷
  • Gauchers cells
    °í¼Î ¼¼Æ÷
  • Germinal cells
    ¹è¾Æ¼¼Æ÷(ÛÏä´á¬øà)
  • Giant pyramidal cells
    Å«ÇǶó¹Ô½Å°æ¿ø(ãêÌèêª)
  • Glandular cells
    ¼±¼¼Æ÷(àÍá¬øà)
  • Glial cells(neuroglia)
    ¾Æ±³¼¼Æ÷(ä¹Îïá¬øà)
  • Glomus cells
    »ç±¸¼¼Æ÷(ÞêÏ¹á¬øà)
  • Goblet cells
    ¼úÀÜ(íÓ)¼¼Æ÷, ¹è»ó¼¼Æ÷(ÛÊßÒá¬øà)
  • Golgi cells, cerebellar
    °ñÁö¼¼Æ÷(á¬øà), ¼Ò³ú(á³Òà)ÀÇ
  • Hair cells
    ¸ð¼¼Æ÷(Ù½á¬øà)
  • Helper T cells
    º¸Á¶ T¼¼Æ÷
  • High-threshold cells
    °í¿ªÄ¡¼¼Æ÷(ÍÔ ö·á¬øà)
  • Hofbauer cells
    È£ÇÁ¹Ù¿ì¾î¼¼Æ÷.
  • Horizontal cells
    ¼öÆò¼¼Æ÷(â©øÁá¬øà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • crypt cells
    Àå»ù¼¼Æ÷(¡­á¬øà)
  • cytotrophoblastic cells
    ¼¼Æ÷¿µ¾ç¸ð¼¼Æ÷(á¬øàç½å×Ù½á¬øà)
  • diploid cells
    À̹èü¼¼Æ÷.
  • enterochromaffin cells
    ÀåÅ©·Òģȭ¼º ¼¼Æ÷
  • epithelial cells
    »óÇǼ¼Æ÷
  • ethmoid cells
    »ç°ñºÀ¼Ò, »ç°ñ¹úÁý{ÇØ}
  • ethmoidal air cells
    »ç°ñ¹úÁý, »ç°ñºÀ¼Ò(ÞèÍéÜðáµ).
  • ethmoidal air cells
    »ç°ñºÀ¼Ò, »ç°ñ¹úÁý{ÇØ}
  • ethmoidal cells
    ¹úÁý
  • extravasation of tumor cells
    Ç÷°ü¿Ü À¯Ãâ
  • foam cells
    Æ÷¸»¼¼Æ÷(øÜØÈá¬øà)
  • follicular dendritic cells
    ¸ð³¶¼öÁö»ó¼¼Æ÷
  • foveolar cells
    ¼Ò¿Í¼¼Æ÷
  • gaucher cells
    °í½¦¼¼Æ÷, Gaucher ¼¼Æ÷
  • goblet cells
    ¹è»ó¼¼Æ÷
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Anterior cells
    ¾Õ¹úÁý
    [¿¾ ¿ë¾î] ÀüºÀ¼Ò
  • Spermatogenic cells
    Á¤Àڹ߻ý¼¼Æ÷
    [¿¾ ¿ë¾î] Á¤¼¼Æ÷
  • Connective tissue cells
    °áÇÕÁ¶Á÷¼¼Æ÷
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷¼¼Æ÷
  • Posterior cells
    µÚ¹úÁý
    [¿¾ ¿ë¾î] ÈĺÀ¼Ò
  • Middle cells
    Áß°£¹úÁý
    [¿¾ ¿ë¾î] ÁߺÀ¼Ò
  • Blood cells
    Ç÷¾×¼¼Æ÷ [Ç÷±¸]
    [¿¾ ¿ë¾î] Ç÷¾×¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • wool fat
    ¾çÅÐÁö¹æ(ò·Û¸)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phase evolution of fat suppression
    À§»ó¼±È¸ Áö¹æ¾ïÁ¦
  • subcutaneous fat
    ÇÇÇÏÁö¹æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
FAT family attitudes test; fluorescent antibody technique; fluorescent antibody test
FES family environment scale; fat embolism syndrome; flame emission spectroscopy; forced expiratory spir...
FF degree of fineness of abrasive particles; fat-free; father factor; fecal frequency; fertility factor...
FFDW fat-free dry weight
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AVF Abdominal visceral fat
BF Body fat
BFM Body fat mass
BF% Body fat percentage
FL Fat
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pararenal fat pad
    ÄáÆÏ ÁÖÀ§ Áö¹æÃ¼
  • perirenal fat
    ½Å ÁÖÀ§ Áö¹æ
  • polyunsaturated fat
    ´ÙºÒÆ÷È­ Áö¹æ
    carbon chain¿¡¼­ ÇÑ °³ ÀÌ»óÀÇ ÀÌÁß °áÇÕÀ» °®°í ÀÖ´Â Áö¹æ»êÀ» ÇÔÀ¯ÇÏ´Â Áö¹æ.
  • serum neutral fat
    Ç÷û Áß¼º Áö¹æ
    Ç÷û Áß¼º Áö¹æÀº ´ëºÎºÐÀÌ Æ®¸®±Û¸®¼¼¶óÀ̵åÀ̰í, ±× ³óµµ´Â À½½Ä¹°ÀÇ ¿µÇâÀ» ¹Þ´Â´Ù.
  • traumatic fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • white fat tissue
    ¹é»ö Áö¹æÁ¶Á÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
split fat Free fatty acids, as reduced by the action of lipases, neutral fats, or phospholipids.
(05 Mar 2000)
neutral fat A triester of fatty acids and glycerol (i.e., triacylglycerol).
(05 Mar 2000)
subcutaneous fat necrosis of newborn Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum.
(05 Mar 2000)
dermal-fat graft A dermal graft with attached subcutaneous fat.
Synonym: adipodermal graft.
(05 Mar 2000)
dietary fat <nutrition> Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados.
(12 Dec 1998)
diet, fat-restricted A diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of hyperlipidemia.
(12 Dec 1998)
Imlach's fat-pad Fat surrounding the round ligament of the uterus in the inguinal canal.
(05 Mar 2000)
infrapatellar fat body The fatty mass that occupies the area between the patellar ligament and the infrapatellar synovial fold of the knee joint.
Synonym: corpus adiposum infrapatellare, infrapatellar fat body.
(05 Mar 2000)
infrapatellar fat-pad The fatty mass that occupies the area between the patellar ligament and the infrapatellar synovial fold of the knee joint.
Synonym: corpus adiposum infrapatellare, infrapatellar fat body.
(05 Mar 2000)
ischiorectal fat-pad The fat within the ischiorectal fossa.
Synonym: corpus adiposum fossae ischiorectalis, fat body of ischiorectal fossa.
(05 Mar 2000)
orbital fat-pad The mass of fat contained in the orbit that contributes to the support of the eyeball.
Synonym: corpus adiposum orbitae, fat body of orbit.
(05 Mar 2000)
otoba fat <chemistry> A colourless buttery substance obtained from the fruit of Myristica otoba, a species of nutmeg tree.
Source: Websters Dictionary
(01 Mar 1998)
embolism, fat Embolism caused by fat entering the circulation. It is often seen after fractures of large bones or after corticosteriod administration.
(12 Dec 1998)
epicardial fat sign <radiology> Two lucent lines on lateral CXR anterior to heart, subepicardial fat around LAD, anterior mediastinal fat, lines seen in 40% of all lateral CXRs, if separation greater than 2 mm most likely to be consider pericardial effusion or thickening
(12 Dec 1998)
faecal fat determination <investigation> A test that measures the amount of fat in the stool and the percentage of dietary fat that is absorbed. This test is used to evaluate potential fat malabsorption syndromes. Stools are collected for 24 hours. Normal values include less than 7 grams of fat per 24 hours, based on a diet of 100 grams of fat per day for 3 days before the test.
Decreased fat absorption can be seen in biliary stricture, biliary cancer, celiac sprue, cholelithiasis, chronic pancreatitis, Crohn's disease, cystic fibrosis, acute pancreatitis, pancreatic cancer, radiation enteritis, short bowel syndromes (post surgical) and Whipple's disease.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á